.jpg)
Kimberly-Clark and Kenvue announced that their shareholders overwhelmingly approved all proposals required for Kimberly-Clark to complete its acquisition of Kenvue. The votes took place during the companies’ respective Special Meetings of Shareholders held this week, reinforcing investor alignment around the strategic transaction.
According to preliminary results, approximately 96% of the shares present at Kimberly-Clark’s Special Meeting voted in favor of issuing common stock in connection with the transaction. At Kenvue’s Special Meeting, approximately 99% of the votes cast approved the merger agreement, representing about 77% of all outstanding shares.
“We are grateful to Kimberly-Clark shareholders who voted resoundingly in favor of our merger with Kenvue,” said Mike Hsu, Chairman and Chief Executive Officer of Kimberly-Clark. “This is an exciting milestone and advances our efforts to build a global leader in health and well-being that will raise the standard of care for billions of people worldwide and generate significant shareholder value. Kimberly-Clark and Kenvue leadership teams are working closely on critical integration planning efforts, further strengthening our enthusiasm and confidence in the opportunity ahead.”
Kenvue CEO Kirk Perry also highlighted shareholder support for the transaction. “We thank Kenvue shareholders for their strong support in approving our transaction with Kimberly-Clark,” he said. “As we continue moving toward closing the transaction later this year, we remain confident in the growth opportunities ahead for the combined company as a global health and well-being leader. By bringing together our portfolios and teams, we can accelerate innovation, expand access to our trusted brands, and deliver greater benefits to customers and consumers worldwide. We look forward to reaching more consumers with our iconic brands as part of Kimberly-Clark.”
Final voting results remain subject to certification by the companies’ independent election inspectors and will subsequently be filed with the U.S. Securities and Exchange Commission (SEC) through separate Current Reports on Form 8-K.
The transaction is expected to close in the second half of 2026, subject to applicable regulatory approvals and customary closing conditions.
